Positive ARTISTRY-2 Trial Results for BIC LEN H...

By HEOR Staff Writer

December 17, 2025

BIC/LEN HIV Regimen Delivers Non-Inferior Results in ARTISTRY-2 Gilead Sciences announced positive topline results from the Phase 3 ARTISTRY-2 trial, demonstrating that ...
Accelerating Tec-Dara Multiple Myeloma Therapy Review: A Game Changer for Pat...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
Arexvy RSV Vaccine Expansion: Broader Access and Impact on Adult Health Outcomes
AI Governance Pharmaceuticals: Ensuring Ethical AI Integration in the Medicin...
Innovations in Haematology Cell Therapy at ASH 2025
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before...